AI Explorations
Our AI explorations are designed to catalyze innovation and inspire visionary AI solutions that draw leading technologists into the field and meaningfully accelerate Alzheimer’s and related dementias research. The first of these efforts is the Alzheimer’s Insights AI Prize, which engages and challenges the global AI community to reimagine what’s possible in understanding and advancing the field.
About the Alzheimer's Insights AI Prize
The Alzheimer's Insights AI Prize is a global, open competition designed to accelerate discovery in Alzheimer's and related dementias through agentic AI.
With more than 55 million people worldwide currently living with Alzheimer's disease and related dementias, there is an urgent need to transform research timelines. Recent breakthroughs in new treatments and diagnostics provide hope, but there is potential to accelerate the pace of discovery and development even further.
The competition was designed to offer a $1 million prize to the team that develops the most innovative agentic AI solution — AI capable of independent planning, reasoning, and action — to accelerate breakthrough discoveries from existing Alzheimer's data. These systems can independently analyze vast datasets and uncover hidden insights, tackling the disease's complexity across multiple biological pathways.
Winning AI tools will be made available via AD Workbench.
Meet the Winning Teams
Biomni-AD and Prima Mente have won the Alzheimer's Insights AI Prize, with each team awarded $1M.
Originally designed to award a single $1M prize, the competition expanded to name two winners—doubling the total prize amount to $2M—reflecting both the exceptional quality of submissions and the pressing need for innovative approaches in the field.
Learn more about both winning teams and their winning pitches below and stay tuned to learn when Biomni-AD and Prima Mente’s tools become available on AD Workbench.
Follow us on LinkedIn for ongoing AI Exploration and AD Workbench updates.
Team: Biomni-AD
Project: Biomni-AD: A General Purpose AI Co-Scientist with Unified Alzheimer's Data Integration
Team: Prima Mente
Project: PARTHENON: Platform for multi-Agent Reasoning and Therapeutic Hypotheses Evaluation using Networks of Neurological virtual cells
Meet the Other Finalist Teams
Learn more about the other three exceptional finalist teams below.
Team: Aletheia
Project: Agentic AI Platform for Alzheimer's Disease Drug Discovery
Team: corteX
Project: AlzSage — Agentic AI for Personalized Healthcare and Accelerated Research in ADRD
Team: Fingerprint
Project: Decoding Precision Signatures in Alzheimer’s with Agentic AI - Optimal Therapeutic Strategy and Multidomain Intervention Guidance
November 2025
The data that researchers have to consider different ideas is so much better than even five years ago, so this is the time to think, 'let’s double down on this disease.' AI is going to impact everything we do. The biology of the brain is so complex that AI’s ability to find meaning in large amounts of data means that this research is going to go a lot faster.
AI Prize Process
The application process closed in September 2025. Ten semifinalists pitched on the sidelines of the Clinical Trials on Alzheimer’s Disease (CTAD) conference in December 2025. Five finalists were invited to present to a judging panel on March 17, 2026, during the Alzheimer’s Insights Summit 3 at the 20th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD) in Copenhagen. Two winning teams were announced on March 20, 2026.